| Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC) (NCT05913427) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2022-06-08 |
| The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma (NCT05344027) | King's College Hospital NHS Trust | 2022-04-11 |
| Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma (NCT05036434) | National Cancer Center, Korea | 2021-11-15 |
| Milademetan in Advanced/Metastatic Solid Tumors (NCT05012397) | Rain Oncology Inc | 2021-11-01 |
| Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma (NCT04318730) | West China Hospital | 2020-10-01 |
| Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) (NCT04373265) | Corcept Therapeutics | 2020-09-30 |
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (NCT04187404) | Enterome | 2020-07-23 |
| Natural History Study of Children and Adults With Adrenocortical Cancer (ACC) (NCT04447014) | National Cancer Institute (NCI) | 2020-06-25 |
| Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) (NCT04358107) | National Cancer Institute (NCI) | 2020-04-20 |
| First-in-human Evaluation of [18F]CETO (NCT05361083) | Uppsala University | 2019-09-01 |
| Cabozantinib in Advanced Adrenocortical Carcinoma (NCT03612232) | Wuerzburg University Hospital | 2019-06-04 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431) | Fusion Pharmaceuticals Inc. | 2019-01-17 |
| A Prospective Cohort Study for Patients With Adrenal Diseases (NCT03474237) | Seoul National University Hospital | 2018-10-01 |
| Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma (NCT03723941) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2018-07-20 |
| Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors (NCT03333616) | Dana-Farber Cancer Institute | 2017-12-28 |
| Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma (NCT03127774) | Columbia University | 2017-09-22 |
| Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma (NCT03145285) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2017-04-18 |
| Familial Investigations of Childhood Cancer Predisposition (NCT03050268) | St. Jude Children's Research Hospital | 2017-04-06 |
| Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield (NCT02324647) | University Medical Center Groningen | 2015-01-01 |
| Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma (NCT02015026) | National Cancer Institute (NCI) | 2013-12-13 |
| Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma (NCT01898715) | Millendo Therapeutics, Inc. | 2013-08-13 |
| Surgery and Heated Chemotherapy for Adrenocortical Carcinoma (NCT01833832) | National Cancer Institute (NCI) | 2013-04-12 |
| Possible New Therapy for Advanced Cancer (NCT01832974) | INSYS Therapeutics Inc | 2012-12-01 |
| Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma (NCT01514526) | Spanish Oncology Genito-Urinary Group | 2012-01-01 |
| A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients (NCT01262235) | Arbutus Biopharma Corporation | 2010-12-01 |
| A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma (NCT00924989) | Astellas Pharma Inc | 2009-12-01 |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features (NCT01048892) | Children's Oncology Group | 2009-09-01 |
| Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients (NCT00786110) | University of Turin, Italy | 2008-04-01 |
| Efficacy of Adjuvant Mitotane Treatment (ADIUVO) (NCT00777244) | University of Turin, Italy | 2008-04-01 |
| Evaluation of Side Effects of Mitotane (NCT00568139) | University of Wuerzburg | 2008-01-01 |
| Sunitinib in Refractory Adrenocortical Carcinoma (NCT00453895) | University of Wuerzburg | 2007-07-01 |
| Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma (NCT00469469) | Dartmouth-Hitchcock Medical Center | 2007-05-01 |
| Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy (NCT00454103) | University of Wuerzburg | 2007-03-01 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer (NCT00436410) | National Institutes of Health Clinical Center (CC) | 2006-12-01 |
| Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma (NCT00324012) | Rigshospitalet, Denmark | 2006-04-01 |
| Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma (NCT00457587) | University of Wuerzburg | 2005-09-01 |
| German Adrenocortical Carcinoma Registry (NCT00453674) | University of Wuerzburg | 2003-01-01 |
| Adrenal Tumors - Pathogenesis and Therapy (NCT00669266) | University of Wuerzburg | 2002-09-01 |
| Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging (NCT00445718) | Children's Oncology Group | 2001-07-01 |
| Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors (NCT00003038) | Mayo Clinic | 1997-10-01 |
| S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery (NCT00002921) | SWOG Cancer Research Network | 1997-03-01 |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors (NCT00002608) | Ottawa Regional Cancer Centre | 1994-05-01 |